Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
DBV Technologies is a global clinical stage biopharmaceutical company focused on epicutaneous immunotherapy using Viaskin peanut patch to treat peanut allergy and address immunologic diseases. The Talent Acquisition role is based in Warren, NJ, requiring on-site presence 3–4 days a week with compensation in the $130k–$150k per year range.
Responsibilities include sourcing, screening, coordinating interviews, ensuring a positive candidate experience, and end-to-end ATS management.
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin® peanut patch, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin. Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy. Tomorrow, as pioneers, we will continue to explore the broad applications of this potential new class of immunotherapy, including treatments for patients suffering from inflammatory and autoimmune diseases.
Location: Warren - NJ --3 days a week on site/ 4 days on site preferred
Salary Range:130-150K per annum
Behavioral skills: